SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-11-031546
Filing Date
2011-05-27
Accepted
2011-05-27 15:40:55
Documents
2
Period of Report
2011-05-24

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c18067_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c18067_3x1.xml 3 1563
2 POWER OF ATTORNEY c18067_24.htm EX-24 2276
  Complete submission text file 0001209191-11-031546.txt   5326
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 399 EAST 72ND STREET - 15E NEW YORK NY 10021
Business Address
Hradsky Gregory T. (Reporting) CIK: 0001439092 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 11878155